JP2013517264A5 - - Google Patents

Download PDF

Info

Publication number
JP2013517264A5
JP2013517264A5 JP2012548527A JP2012548527A JP2013517264A5 JP 2013517264 A5 JP2013517264 A5 JP 2013517264A5 JP 2012548527 A JP2012548527 A JP 2012548527A JP 2012548527 A JP2012548527 A JP 2012548527A JP 2013517264 A5 JP2013517264 A5 JP 2013517264A5
Authority
JP
Japan
Prior art keywords
pyridin
phenyl
amine
methylsulfonyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012548527A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013517264A (ja
JP5735986B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/050192 external-priority patent/WO2011086531A2/en
Publication of JP2013517264A publication Critical patent/JP2013517264A/ja
Publication of JP2013517264A5 publication Critical patent/JP2013517264A5/ja
Application granted granted Critical
Publication of JP5735986B2 publication Critical patent/JP5735986B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012548527A 2010-01-18 2011-01-17 新規抗マラリア剤 Expired - Fee Related JP5735986B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29582110P 2010-01-18 2010-01-18
US61/295,821 2010-01-18
PCT/IB2011/050192 WO2011086531A2 (en) 2010-01-18 2011-01-17 New anti-malarial agents

Publications (3)

Publication Number Publication Date
JP2013517264A JP2013517264A (ja) 2013-05-16
JP2013517264A5 true JP2013517264A5 (cg-RX-API-DMAC10.html) 2014-02-13
JP5735986B2 JP5735986B2 (ja) 2015-06-17

Family

ID=43759659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012548527A Expired - Fee Related JP5735986B2 (ja) 2010-01-18 2011-01-17 新規抗マラリア剤

Country Status (17)

Country Link
US (1) US9024033B2 (cg-RX-API-DMAC10.html)
EP (1) EP2526090B1 (cg-RX-API-DMAC10.html)
JP (1) JP5735986B2 (cg-RX-API-DMAC10.html)
CN (1) CN102812006B (cg-RX-API-DMAC10.html)
BR (1) BR112012017713A2 (cg-RX-API-DMAC10.html)
CA (1) CA2787121C (cg-RX-API-DMAC10.html)
DK (1) DK2526090T3 (cg-RX-API-DMAC10.html)
ES (1) ES2551875T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20151143T1 (cg-RX-API-DMAC10.html)
HU (1) HUE027946T2 (cg-RX-API-DMAC10.html)
ME (1) ME02315B (cg-RX-API-DMAC10.html)
PL (1) PL2526090T3 (cg-RX-API-DMAC10.html)
PT (1) PT2526090E (cg-RX-API-DMAC10.html)
RS (1) RS54339B1 (cg-RX-API-DMAC10.html)
SI (1) SI2526090T1 (cg-RX-API-DMAC10.html)
SM (1) SMT201500291B (cg-RX-API-DMAC10.html)
WO (1) WO2011086531A2 (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106518856B (zh) 2008-12-19 2020-04-28 沃泰克斯药物股份有限公司 用作atr激酶抑制剂的化合物
JP2013526540A (ja) 2010-05-12 2013-06-24 バーテックス ファーマシューティカルズ インコーポレイテッド Atrキナーゼ阻害剤として有用な化合物
MX2012013082A (es) * 2010-05-12 2013-05-09 Vertex Pharma Derivados de 2-aminopiridina utiles como iinhibidores de cinasa atr.
SG185524A1 (en) 2010-05-12 2012-12-28 Vertex Pharma Compounds useful as inhibitors of atr kinase
US8440652B2 (en) * 2011-03-04 2013-05-14 Lexicon Pharmaceuticals, Inc. MST1 kinase inhibitors and methods of their use
EP3733185B1 (en) 2011-09-30 2022-12-07 Vertex Pharmaceuticals Incorporated Treating non-small cell lung cancer with atr inhibitors
CA2850566C (en) 2011-09-30 2022-05-03 Vertex Pharmaceuticals Incorporated Process for making 4-[chloro-n-hydroxycarbonimidoyl]phenyl derivative
PL2814820T3 (pl) * 2012-02-17 2017-01-31 University Of Cape Town Środki antymalaryczne
EP2833973B1 (en) 2012-04-05 2017-09-13 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of atr kinase and combination therapies thereof
US8999632B2 (en) 2012-10-04 2015-04-07 Vertex Pharmaceuticals Incorporated Method for measuring ATR inhibition mediated increases in DNA damage
US9006250B2 (en) * 2013-03-15 2015-04-14 Dow Agrosciences Llc 4-amino-6-(heterocyclic)picolinates and 6-amino-2-(heterocyclic)pyrimidine-4-carboxylates and their use as herbicides
JP6543241B2 (ja) 2013-03-15 2019-07-10 ダウ アグロサイエンシィズ エルエルシー 4−アミノ−6−(複素環式)ピコリネートおよび6−アミノ−2−(複素環式)ピリミジン−4−カルボキシレートならびに除草剤としてのそれらの使用
BR112016024484A2 (pt) * 2014-04-24 2017-08-15 Novartis Ag derivados de aminopiridina como inibidores de fosfatidilinositol 3-quinase
PL3134395T3 (pl) 2014-04-24 2018-07-31 Novartis Ag Pochodne pirazyny jako inhibitory 3-kinazy fosfatydyloinozytolu
JP6433509B2 (ja) 2014-04-24 2018-12-05 ノバルティス アーゲー ホスファチジルイノシトール3−キナーゼ阻害薬としてのアミノピラジン誘導体
JP7109919B2 (ja) * 2015-03-20 2022-08-01 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト Usp7阻害剤化合物及び使用方法
EP3118198A1 (en) * 2015-07-13 2017-01-18 MMV Medicines for Malaria Venture Anti-malarial agents
MX395066B (es) 2015-09-30 2025-03-24 Vertex Pharma Método para tratar cáncer usando una combinación de agentes que dañan el adn e inhibidores de proteína relacionada con ataxia telangiectasia y rad3 (atr).
WO2017067881A1 (en) * 2015-10-19 2017-04-27 Glaxosmithkline Intellectual Property Development Limited Pyrazine compounds for use in the treatment of parasitic protozoal infections
GB201603104D0 (en) * 2016-02-23 2016-04-06 Ucb Biopharma Sprl Therapeutic agents
EP3254679A1 (de) 2016-06-09 2017-12-13 Christian-Albrechts-Universität zu Kiel Wirkstoffe gegen protozoen und bakterien
RU2020124116A (ru) * 2017-12-22 2022-01-25 Хиберселл, Инк. Производные арил-бипиридинамина в качестве ингибиторов фосфатидилинозитолфосфаткиназы
CR20200464A (es) 2018-03-08 2021-04-14 Incyte Corp Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
EP3842100A1 (en) * 2019-12-24 2021-06-30 The Board Of Regents Of The University Of Texas System Anti-malarial agents
WO2024033280A1 (en) 2022-08-09 2024-02-15 Merck Patent Gmbh Furopyridin and furopyrimidin, inhibitors of pi4k, for use in the treatment of parasite infection and malaria
CA3264304A1 (en) 2022-08-09 2024-02-15 Merck Patent Gmbh FURO-PYRIMIDINE DERIVATIVES
EP4574143A1 (en) 2023-12-21 2025-06-25 Universität Regensburg Inhibitors of plasmodia remodeling enzymes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100574350B1 (ko) * 2004-08-31 2006-04-27 한국화학연구원 2-아미노피리딘 유도체의 제조방법
WO2007032016A1 (en) * 2005-09-12 2007-03-22 Council Of Scientific And Industrial Research An antimalarial baylis-hillman adducts and a process for the preparation thereof
EP1900727A1 (en) 2006-08-30 2008-03-19 Cellzome Ag Aminopyridine derivatives as kinase inhibitors
CN101555248B (zh) * 2009-05-22 2011-06-22 北京欧凯纳斯科技有限公司 一种多取代1,5-萘啶化合物的制备方法

Similar Documents

Publication Publication Date Title
JP2013517264A5 (cg-RX-API-DMAC10.html)
HRP20151143T1 (hr) Novi antimalarijski agensi
RU2457207C2 (ru) Активаторы глюкокиназы
CN101970410B (zh) 吡啶基氨基乙酸化合物
JP2020516671A5 (cg-RX-API-DMAC10.html)
JP2017501981A5 (cg-RX-API-DMAC10.html)
JP2016164184A5 (cg-RX-API-DMAC10.html)
JP2013544840A5 (cg-RX-API-DMAC10.html)
JP2020521730A5 (cg-RX-API-DMAC10.html)
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
JP2010513444A5 (cg-RX-API-DMAC10.html)
JP2015517580A5 (cg-RX-API-DMAC10.html)
JP2020536116A5 (cg-RX-API-DMAC10.html)
JP2013517278A5 (cg-RX-API-DMAC10.html)
JP2008513514A5 (cg-RX-API-DMAC10.html)
JP2009525285A5 (cg-RX-API-DMAC10.html)
JP2016522246A5 (cg-RX-API-DMAC10.html)
RU2012126989A (ru) 2-амино-5,5-дифтор-5,6-дигидро-4н-оксазины в качестве ингибиторов васе 1 и(или) васе 2
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2010504280A5 (cg-RX-API-DMAC10.html)
JP2007508346A5 (cg-RX-API-DMAC10.html)
JP2014511869A5 (cg-RX-API-DMAC10.html)
JP2005526814A5 (cg-RX-API-DMAC10.html)
JP2017508766A5 (cg-RX-API-DMAC10.html)
JP2018503673A5 (cg-RX-API-DMAC10.html)